Tomas Noli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Tomas Noli has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
Adrien M. Vaquie
Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK
1 shared publication- Amel Zulji
Division of Neuroimmunology, Department of Neurology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
1 shared publication - Ben Emery
Jungers Center for Neurosciences Research, Department of Neurology, Oregon Health & Science University, Portland, USA
1 shared publication - Brian Popko
Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
1 shared publication - Celine Geywitz
Division of Neuroimmunology, Department of Neurology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
1 shared publication - Daniel H. Geschwind
UCLA
1 shared publication
Latest Publications
- Open Access
- 1 April 2026
- Published by Springer Nature in Nature
- Vol. 653 (8115) , 809-818
DNA damage burden causes selective CUX2 neuron loss in neuroinflammation
Neurodegeneration shows regional and cell-type-specific patterns in ageing and disease 1 , but the underlying mechanisms for cell-type-specific neuronal losses remain poorly understood. Previous studies have shown that upper cortical layer thinning occurs in progressive human multiple sclerosis (MS) and that cortical layer 2 and layer 3 (L2/3) excitatory neurons (L2/3ENs) that express CUT-like homeobox 2 ( CUX2 ) are selectively vulnerable to degeneration 2 . Here we report that L2/3ENs within MS cortical lesions have an elevated DNA damage burden. DNA damage and selective loss of L2/3ENs were recapitulated in diverse mouse models of demyelination and pan-cortical inflammation, confirming their intrinsic vulnerability. Functions of Cux2 and activating transcription factor 4 ( Atf4 ) were essential for resilience of L2/3ENs during postnatal neuroinflammation, acting in neurons to enhance DNA double-strand break repair. Interferon-γ, a cytokine implicated in MS pathogenesis 3,4 , was sufficient to elevate levels of reactive oxygen species, leading to DNA damage-mediated neuronal death in vitro, and caused selective depletion of L2/3 neurons in mice. These findings indicate that DNA damage burden and inadequate repair in CUX2 + L2/3ENs contributes to selective vulnerability in neuroinflammatory injury.
- 1 April 2026
- Published by Springer Nature in Nature
- Vol. 653 (8115) , 809-818
Open AccessDNA damage burden causes selective CUX2 neuron loss in neuroinflammation
Neurodegeneration shows regional and cell-type-specific patterns in ageing and disease 1 , but the underlying mechanisms for cell-type-specific neuronal losses remain poorly understood. Previous studies have shown that upper cortical layer thinning occurs in progressive human multiple sclerosis (MS) and that cortical layer 2 and layer 3 (L2/3) excitatory neurons (L2/3ENs) that express CUT-like homeobox 2 ( CUX2 ) are selectively vulnerable to degeneration 2 . Here we report that L2/3ENs within MS cortical lesions have an elevated DNA damage burden. DNA damage and selective loss of L2/3ENs were recapitulated in diverse mouse models of demyelination and pan-cortical inflammation, confirming their intrinsic vulnerability. Functions of Cux2 and activating transcription factor 4 ( Atf4 ) were essential for resilience of L2/3ENs during postnatal neuroinflammation, acting in neurons to enhance DNA double-strand break repair. Interferon-γ, a cytokine implicated in MS pathogenesis 3,4 , was sufficient to elevate levels of reactive oxygen species, leading to DNA damage-mediated neuronal death in vitro, and caused selective depletion of L2/3 neurons in mice. These findings indicate that DNA damage burden and inadequate repair in CUX2 + L2/3ENs contributes to selective vulnerability in neuroinflammatory injury.